Association of CD117 and HLA-DR expression with shorter overall survival and/or progression-free survival in patients with multiple myeloma treated with bortezomib and thalidomide combination treatment without transplantation

Certain immunophenotypes in multiple myeloma (MM), including CD56 and CD117, have been reported to be associated with overall survival (OS). However, previous reports have ignored the impact of different treatment regimens and the long-term prognostic value of immunophenotyping in MM when treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Zhou, Xin, Zhu, Jian-Wei, Ye, Jian-Nan, Guo, Hong-Feng, Sun, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176261/
https://www.ncbi.nlm.nih.gov/pubmed/30344721
http://dx.doi.org/10.3892/ol.2018.9365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176261/
https://www.ncbi.nlm.nih.gov/pubmed/30344721
http://dx.doi.org/10.3892/ol.2018.9365

Ejemplares similares